All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q2 report for Moderna US Inc. on July 18, 2025, reporting $80,000 in lobbying income.

Lobbying for Moderna US Inc. · Pharmaceuticals

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for MODERNA US INC.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Moderna US Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$80,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.